Dosage of Sulfamethoxazole-Trimethoprim for 10-Month-Old with UTI
For a 10-month-old infant with a urinary tract infection, administer sulfamethoxazole-trimethoprim (SMX-TMP) at a dose of 40 mg/kg/day of sulfamethoxazole plus 8 mg/kg/day of trimethoprim, divided into two doses given every 12 hours for 5-7 days.
Dosing Calculation
The WHO Pocket Book guideline provides clear pediatric dosing for UTI: 10 mg/kg trimethoprim plus 40 mg/kg sulfamethoxazole twice daily (BD) for 5 days 1. The FDA label confirms this approach, stating 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, given in two divided doses every 12 hours for 10 days for pediatric UTI 2.
Practical Dosing Example:
- For a 10 kg infant (typical 10-month-old):
- Trimethoprim: 80-100 mg per day (40-50 mg twice daily)
- Sulfamethoxazole: 400 mg per day (200 mg twice daily)
- This equals approximately 5 mL of standard suspension (40mg TMP/200mg SMX per 5mL) twice daily
Treatment Duration
A 5-7 day course is appropriate for this age group. The 2026 AAP guideline specifically recommends 5-7 days of antibiotics for children 2 months to 24 months of age with UTI 3. The WHO guideline supports 5 days for uncomplicated UTI 1, while the FDA label traditionally states 10 days 2. Given the strong recent evidence favoring shorter courses without compromising outcomes, 5-7 days represents optimal stewardship-aligned practice for a 10-month-old.
Critical Safety Considerations
Age Restriction
SMX-TMP is NOT recommended for infants under 2 months of age 2. At 10 months, this infant is well above this threshold. The pharmacokinetic data shows prolonged half-lives in neonates (16.5-19 hours) 4, but by 10 months, drug clearance approaches older pediatric norms.
Monitoring Requirements
- Complete blood count at initiation and monthly if prolonged therapy is needed 5
- Watch for rash (most common adverse effect, occurring 2.5x more frequently than other antibiotics) 6, 7, 6
- Rare but serious: Stevens-Johnson syndrome, neutropenia, thrombocytopenia 8
Alternative Considerations
If SMX-TMP cannot be used due to allergy or resistance:
- Second-line per WHO: Ampicillin IV plus gentamicin IV (as for sepsis dosing) 1
- Consider local resistance patterns—ESBL organisms may require expanded-spectrum cephalosporins 9
- Nitrofurantoin is an option for uncomplicated cystitis in older children but has limited data in infants under 1 year
Common Pitfalls
- Underdosing: Using adult weight-based calculations instead of pediatric mg/kg dosing
- Excessive duration: The traditional 10-14 day course is no longer evidence-based for uncomplicated UTI 3
- Ignoring contraindications: Never use in infants <2 months, those with G6PD deficiency, or significant renal impairment without dose adjustment 2
- Failure to confirm diagnosis: Ensure proper urine collection (catheterization or suprapubic aspiration preferred in infants) and culture confirmation before completing full course 3
The evidence strongly supports SMX-TMP as effective first-line therapy for pediatric UTI when local resistance patterns permit, with the caveat that resistance to SMX-TMP has increased significantly in some regions, making empiric culture-guided therapy essential 10, 11.